HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tamiko Tamanaha Selected Research

Paraganglioma (Paragangliomas)

8/2009R27X nonsense mutation of the SDHB gene in a patient with sporadic malignant paraganglioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tamiko Tamanaha Research Topics

Disease

4Heart Failure
01/2022 - 05/2014
4Type 2 Diabetes Mellitus (MODY)
11/2020 - 01/2015
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
08/2019 - 01/2015
3Hashimoto Disease (Thyroiditis, Hashimoto)
01/2015 - 01/2010
2Dyslipidemias (Dyslipidemia)
10/2019 - 01/2010
2Hypertension (High Blood Pressure)
10/2019 - 01/2015
2Homozygous Familial Hypercholesterolemia
08/2019 - 10/2017
2Atherosclerosis
08/2019 - 10/2017
2Neoplasms (Cancer)
09/2011 - 08/2009
1Atrial Fibrillation
01/2022
1Ventricular Tachycardia
01/2022
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
01/2022
1Cognitive Dysfunction
11/2020
1Alzheimer Disease (Alzheimer's Disease)
11/2020
1Heart Diseases (Heart Disease)
03/2020
1Left Ventricular Dysfunction
03/2020
1Obesity
10/2019
1Glucose Intolerance
10/2019
1Atherosclerotic Plaque (Atheroma)
10/2019
1Hypoglycemia (Reactive Hypoglycemia)
10/2019
1Cardiovascular Diseases (Cardiovascular Disease)
08/2019
1Peripheral Arterial Disease
10/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2015
1Thyroiditis
03/2014
1Immunoglobulin G4-Related Disease
03/2014
1Stroke (Strokes)
11/2013
1Hyperemia
11/2013
1Deafness (Deaf Mutism)
01/2013
1Barakat syndrome
01/2013
1Hypoparathyroidism
01/2013
1Hyperaldosteronism (Conn Syndrome)
05/2012
1Thyroid Neoplasms (Thyroid Cancer)
01/2012
1Hyperthyroidism
01/2012
1Goiter
01/2012
1Adenoma (Adenomas)
01/2012
1Pituitary ACTH Hypersecretion
09/2011
1Pituitary Neoplasms (Pituitary Adenoma)
09/2011
1ACTH-Secreting Pituitary Adenoma
09/2011
1Hypothyroidism
01/2010
1Thyrotoxicosis
01/2010
1Paraganglioma (Paragangliomas)
08/2009

Drug/Important Bio-Agent (IBA)

4oxidized low density lipoproteinIBA
08/2019 - 01/2015
3Glucose (Dextrose)FDA LinkGeneric
11/2020 - 10/2019
3Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
10/2019 - 01/2015
3LDL Lipoproteins (beta Lipoproteins)IBA
08/2019 - 01/2015
2LipidsIBA
10/2019 - 01/2010
2SubtilisinIBA
05/2016 - 01/2015
2Brain Natriuretic Peptide (Natrecor)FDA Link
01/2015 - 05/2014
2Nonsense Codon (Nonsense Mutation)IBA
01/2013 - 08/2009
1PlakophilinsIBA
01/2022
1Ketone BodiesIBA
03/2020
16- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
03/2020
1SodiumIBA
03/2020
1Indicators and Reagents (Reagents)IBA
10/2019
1Biomarkers (Surrogate Marker)IBA
10/2019
1HDL LipoproteinsIBA
10/2019
1Fatty Acid-Binding ProteinsIBA
10/2019
1Lipoproteins (Lipoprotein)IBA
08/2019
1Therapeutic UsesIBA
08/2019
1LinagliptinIBA
04/2019
1ApolipoproteinsIBA
05/2016
1LDL Receptors (LDL Receptor)IBA
05/2016
1anti-thyroglobulinIBA
01/2015
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2015
1LDL CholesterolIBA
01/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2015
1FurinIBA
01/2015
1Hemoglobins (Hemoglobin)IBA
05/2014
1AntibodiesIBA
03/2014
1Immunoglobulin G (IgG)IBA
03/2014
1Oral ContraceptivesIBA
11/2013
1Estrogens (Estrogen)FDA Link
11/2013
1DNA (Deoxyribonucleic Acid)IBA
01/2013
1Codon (Codons)IBA
01/2013
1AldosteroneIBA
05/2012
1IodineIBA
01/2012
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
01/2012
1Adrenocorticotropic Hormone (ACTH)FDA Link
09/2011
1hydroxide ionIBA
01/2010
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2010
1Chromogranin AIBA
08/2009

Therapy/Procedure

3Blood Component Removal (Apheresis)
08/2019 - 01/2015
3Therapeutics
01/2015 - 01/2010
1Electric Countershock (Cardioversion)
01/2022
1Glycemic Control
10/2019